Stay updated on NUC-7738 in Advanced Solid Tumours: Clinical Trial
Sign up to get notified when there's something new on the NUC-7738 in Advanced Solid Tumours: Clinical Trial page.

Latest updates to the NUC-7738 in Advanced Solid Tumours: Clinical Trial page
- Check4 days agoChange DetectedAdded Phase II melanoma cohort eligibility expansion for NUC-7738 + pembrolizumab: metastatic cutaneous melanoma patients with measurable disease who progressed on up to two prior lines, with at least one PD-1/PD-L1-containing regimen. The progression-in-last-12-months constraint was removed, and the record shows Revision: v3.3.4 with Last Update Posted 2026-01-12.SummaryDifference0.7%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedFooter now displays Revision: v3.3.3, and the HHS Vulnerability Disclosure link and Revision: v3.3.2 have been removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed on the page. This is a metadata update and does not affect the study information presented.SummaryDifference0.0%

- Check62 days agoChange DetectedThe government funding status notice was removed from the page. No other substantive study details were altered; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check83 days agoChange DetectedCore study details and outcomes remain unchanged; the new screenshot shows only superficial formatting changes to layout and typography.SummaryDifference0.4%

- Check105 days agoChange DetectedCore page content updated with a funding/operating status notice and a new version tag (v3.2.0); old version tag (v3.1.0) removed.SummaryDifference2%

Stay in the know with updates to NUC-7738 in Advanced Solid Tumours: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NUC-7738 in Advanced Solid Tumours: Clinical Trial page.